Search research articles
Contact Us
Filters
Showing results (11-20 of 28) with videos related to
Page
of 3
Sort By:
Rheumatology (Oxford, England)
|
May 15, 2024
Can we predict kidney involvement in patients with systemic lupus erythematosus? A retrospective cohort study with independent validation
Spyridon Katechis, Dionysis Nikolopoulos, Sofia Flouda, et al.
Clinical and Experimental Immunology
|
February 7, 2025
Characterization of T-bet expressing B cells in lupus patients indicates a putative prognostic and therapeutic value of these cells for the disease
Athanasios Sachinidis, Maria Trachana, Anna Taparkou, et al.
Expert Opinion on Biological Therapy
|
January 13, 2026
Efficacy of intravenous infliximab in axial spondyloarthritis: impact on disease activity, quality of life, and productivity in subgroups with psoriasis and inflammatory bowel disease
Nikolaos Kougkas, Elpida Skouvaklidou, Dimitrios Deligeorgakis, et al.
Annals of the Rheumatic Diseases
|
February 11, 2021
Lupus or not? SLE Risk Probability Index (SLERPI): a simple, clinician-friendly machine learning-based model to assist the diagnosis of systemic lupus erythematosus
Christina Adamichou, Irini Genitsaridi, Dionysis Nikolopoulos, et al.
Annals of the Rheumatic Diseases
|
November 10, 2019
In an early SLE cohort the ACR-1997, SLICC-2012 and EULAR/ACR-2019 criteria classify non-overlapping groups of patients: use of all three criteria ensures optimal capture for clinical studies while their modification earlier classification and treatment
Christina Adamichou, Dionysis Nikolopoulos, Irini Genitsaridi, et al.
Mediterranean Journal of Rheumatology
|
May 16, 2020
Development and Implementation of a Pilot Registry for Monitoring the Efficacy and Safety of Novel Therapies in Patients with Systemic Lupus Erythematosus
Christina Adamichou, Irini Flouri, Antonios Fanouriakis, et al.
Mediterranean Journal of Rheumatology
|
March 19, 2020
Comparative analysis of the sensitivity and specificity of the classification criteria and correlation with prognosis of disease in patients with Systemic Lupus Erythematosus
Christina Adamichou, Dionysios Nikolopoulos, Emmanouil Papastefanakis, et al.
Mediterranean Journal of Rheumatology
|
February 6, 2026
Current and Emerging Therapies for Uveitis in Axial Spondyloarthritis: A Scoping Review
Dimitrios Deligeorgakis, Elpida Skouvaklidou, Vasileios Skepastianos, et al.
Mediterranean Journal of Rheumatology
|
May 17, 2024
Focus on Filgotinib in Rheumatoid Arthritis: A Trial-Based Review
Elpida Skouvaklidou, Dimitrios Deligeorgakis, Anastasia Skalkou, et al.
RMD Open
|
October 1, 2025
Systemic lupus erythematosus damage risk index (SLE-DRI): a simple machine learning-based tool for identifying patients at risk for early organ damage
Panagiotis Garantziotis, Dionysis Nikolopoulos, Spyridon Katechis, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 28) with videos related to
Sort By:
Page
of 3
Rheumatology (Oxford, England)
|
May 15, 2024
Can we predict kidney involvement in patients with systemic lupus erythematosus? A retrospective cohort study with independent validation
Spyridon Katechis, Dionysis Nikolopoulos, Sofia Flouda, et al.
Clinical and Experimental Immunology
|
February 7, 2025
Characterization of T-bet expressing B cells in lupus patients indicates a putative prognostic and therapeutic value of these cells for the disease
Athanasios Sachinidis, Maria Trachana, Anna Taparkou, et al.
Expert Opinion on Biological Therapy
|
January 13, 2026
Efficacy of intravenous infliximab in axial spondyloarthritis: impact on disease activity, quality of life, and productivity in subgroups with psoriasis and inflammatory bowel disease
Nikolaos Kougkas, Elpida Skouvaklidou, Dimitrios Deligeorgakis, et al.
Annals of the Rheumatic Diseases
|
February 11, 2021
Lupus or not? SLE Risk Probability Index (SLERPI): a simple, clinician-friendly machine learning-based model to assist the diagnosis of systemic lupus erythematosus
Christina Adamichou, Irini Genitsaridi, Dionysis Nikolopoulos, et al.
Annals of the Rheumatic Diseases
|
November 10, 2019
In an early SLE cohort the ACR-1997, SLICC-2012 and EULAR/ACR-2019 criteria classify non-overlapping groups of patients: use of all three criteria ensures optimal capture for clinical studies while their modification earlier classification and treatment
Christina Adamichou, Dionysis Nikolopoulos, Irini Genitsaridi, et al.
Mediterranean Journal of Rheumatology
|
May 16, 2020
Development and Implementation of a Pilot Registry for Monitoring the Efficacy and Safety of Novel Therapies in Patients with Systemic Lupus Erythematosus
Christina Adamichou, Irini Flouri, Antonios Fanouriakis, et al.
Mediterranean Journal of Rheumatology
|
March 19, 2020
Comparative analysis of the sensitivity and specificity of the classification criteria and correlation with prognosis of disease in patients with Systemic Lupus Erythematosus
Christina Adamichou, Dionysios Nikolopoulos, Emmanouil Papastefanakis, et al.
Mediterranean Journal of Rheumatology
|
February 6, 2026
Current and Emerging Therapies for Uveitis in Axial Spondyloarthritis: A Scoping Review
Dimitrios Deligeorgakis, Elpida Skouvaklidou, Vasileios Skepastianos, et al.
Mediterranean Journal of Rheumatology
|
May 17, 2024
Focus on Filgotinib in Rheumatoid Arthritis: A Trial-Based Review
Elpida Skouvaklidou, Dimitrios Deligeorgakis, Anastasia Skalkou, et al.
RMD Open
|
October 1, 2025
Systemic lupus erythematosus damage risk index (SLE-DRI): a simple machine learning-based tool for identifying patients at risk for early organ damage
Panagiotis Garantziotis, Dionysis Nikolopoulos, Spyridon Katechis, et al.
Page
of 3